Atlas Trials

A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC

Clinical trial NCT06280196 · TERMINATED

Trial details

NCT number
NCT06280196
Sponsor
Bio-Thera Solutions
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2024-07-19
Primary completion
2025-07-30
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.